FDA: Bradycardia Risk With Amiodarone Plus Hep-C AntiviralsFDA: Bradycardia Risk With Amiodarone Plus Hep-C Antivirals

The FDA is updating labeling for Harvoni and Savoldi antivirals after the death of one patient, and pacemaker implantation in three others, who were also on the antiarrhythmic agent. News Alerts

Source: Medscape Cardiology Headlines - March 23, 2015 Category: Cardiology Tags: Cardiology News Alert Source Type: news